logo
logo
Sign in

global Lyme Disease Treatment Market Growth Accelerated by Increasing Prevalence of Lyme Disease

avatar
Pooja salve
global Lyme Disease Treatment Market Growth Accelerated by Increasing Prevalence of Lyme Disease

Lyme disease, also known as Lyme borreliosis, is a tick-borne illness caused by Borrelia burgdorferi bacteria. The infection often begins with a bull's-eye shaped skin rash and can cause fatigue, chills, fever, headache, muscular pain, joint pain, and swollen lymph nodes in later stages if left untreated. Antibiotics such as doxycycline, amoxicillin or cefuroxime axetil are generally prescribed as treatment for Lyme disease.

The global Lyme Disease Treatment Market is estimated to be valued at US$ 1.56 Bn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing prevalence of Lyme disease across the globe has emerged as a key driver for the growth of the Lyme disease treatment market. As per statistics, around 476,000 Americans are diagnosed with Lyme disease each year. Moreover, the tick-borne illness affects around 65,000 people annually in Europe. The rising awareness regarding the disease and its treatment options has resulted in increased diagnosis and management of Lyme disease, thus fueling the demand for antibiotics and other treatment methods. Aggressive marketing strategies by pharmaceutical companies have also propelled the sales of Lyme disease treatment drugs over the recent past.

Segment Analysis

The global Lyme disease treatment market is segmented based on treatment type, route of administration and distribution channel. Among treatment type, the antibiotic treatment segment dominates the market and is expected to continue its dominance during the forecast period. Antibiotic treatment is the first line of defense against Lyme disease and is very effective if administered early during the infection.

Key Takeaways

Global Lyme Disease Treatment Market Demand is estimated to be valued at US$ 1.56 Bn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030.

Regional analysis: North America is expected to hold the largest share of the global Lyme disease treatment market during the forecast period. Rising incidence of lyme disease in the region coupled with increasing awareness regarding its early diagnosis and treatment is a major factor driving the market.

Key players: Key players operating in the Lyme disease treatment market are Pfizer Inc., GlaxoSmithKline plc., Merck & Co. Inc., ALLERGAN, Novartis AG, Mallinckrodt, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Lupin, and Mayne Pharma. Pfizer Inc. currently dominates the market with its doxycycline drug being the first line treatment for Lyme disease.

GlaxoSmithKline plc, in collaboration with Pfizer, is developing a five-valent vaccine (VLA15) for preventing infections caused by Borrelia bacteria which cause Lyme disease. The vaccine is currently in phase 3 clinical trial and if approved, can strengthen GlaxoSmithKline's position in the market.

Merck & Co. Inc. is planning to expand its pipeline of drugs to treat later stage Lyme disease which has potential to drive future growth. Additionally, several small pharmaceutical companies are actively researching newer treatment options which are expected to provide more competition in the market during forecast period.


Get More Insights on this Topic- https://www.rapidwebwire.com/lyme-disease-treatment-market-size-demand-and-forecast-analysis/ 



Explore More Trending Articles on Healthcare Industry- https://allmeaninginhindi.com/understanding-biopharmaceuticals-the-future-of-healthcare-industry/


collect
0
avatar
Pooja salve
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more